Nuvation Bio Inc.
NUVB
$2.88
-$0.02-0.69%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 60.27% | -780.50% | -649.24% | -542.39% | -464.87% |
| Total Depreciation and Amortization | 154.13% | 317.41% | 207.66% | 140.28% | 89.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -92.56% | 5,535.31% | 6,281.89% | 3,778.51% | 3,210.40% |
| Change in Net Operating Assets | 111.41% | -36.29% | -2,415.93% | -432.61% | -154.61% |
| Cash from Operations | -99.73% | -144.42% | -91.79% | -43.39% | -3.87% |
| Capital Expenditure | -525.81% | -146.43% | -134.78% | -55.37% | 69.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 133.33% | 7.69% |
| Cash Acquisitions | -100.73% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 259.88% | 129.28% | 1,130.36% | 299.64% | 89.57% |
| Cash from Investing | 190.50% | 147.36% | 1,275.44% | 325.94% | 135.85% |
| Total Debt Issued | 674.34% | -- | -- | -- | -- |
| Total Debt Repaid | -82.55% | -- | -- | -- | -- |
| Issuance of Common Stock | 131.07% | 1,594.02% | 677.87% | 320.33% | 105.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6,357.62% | 144.44% | -47.29% | 47.65% | 170.62% |
| Foreign Exchange rate Adjustments | 410.26% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,454.15% | 203.38% | 88.15% | 104.94% | 69.80% |